Dexmedetomidine and perioperative analgesia in children.

Autor: Eizaga Rebollar R; Servicio de Anestesiología y Reanimación, Hospital Universitario Puerta de Mar, Cádiz, Spain. Electronic address: ramonchueizaga@hotmail.com., García Palacios MV; Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Puerta de Mar, Cádiz, Spain., Fernández Riobó MC; Servicio de Anestesiología y Reanimación, Hospital Universitario Puerta de Mar, Cádiz, Spain., Torres Morera LM; Servicio de Anestesiología y Reanimación, Hospital Universitario Puerta de Mar, Cádiz, Spain.
Jazyk: angličtina
Zdroj: Revista espanola de anestesiologia y reanimacion [Rev Esp Anestesiol Reanim (Engl Ed)] 2022 Oct; Vol. 69 (8), pp. 487-492. Date of Electronic Publication: 2022 Sep 10.
DOI: 10.1016/j.redare.2022.08.003
Abstrakt: Dexmedetomidine (DEX) is an anaesthetic agent that mimics natural deep sleep and produces minimal cardiorespiratory depression. As such, it is a very valuable option in the management of such a challenging population as paediatric patients. The main objective of this mini review was to evaluate the role of DEX as a perioperative analgesic in children receiving anaesthesia. We searched Google, Pubmed, Embase and the Cochrane Library for articles published between 2010 and 2021, and reviewed various of aspects of DEX, such as pharmacology, effectiveness, safety, and the most recent evidence on its clinical use as an analgesic in paediatric anaesthesia. We also include a cost estimate of perioperative analgesia with DEX.
(Copyright © 2021 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: